Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Malignant Lymphoma

  Free Subscription


Articles published in Br J Dermatol

Retrieve available abstracts of 42 articles:
HTML format
Text format



Single Articles


    April 2019
  1. GOYAL A, Goyal K, Bohjanen K, Pearson D, et al
    Epidemiology of primary cutaneous gamma/delta T-cell lymphoma and subcutaneous panniculitis-like T-cell lymphoma in the United States from 2006-2015: A Surveillance, Epidemiology, and End Results-18 analysis.
    Br J Dermatol. 2019 Apr 5. doi: 10.1111/bjd.17985.
    PubMed     Text format     Abstract available


    March 2019
  2. SEMENOV YR, Rosenberg AR, Herbosa C, Mehta-Shah N, et al
    Health-related quality of life and economic implications of cutaneous T-cell lymphoma.
    Br J Dermatol. 2019 Mar 28. doi: 10.1111/bjd.17941.
    PubMed     Text format     Abstract available


  3. WANG Y, Bagot M
    Updates in cutaneous lymphoma: evidence-based guidelines for the management of cutaneous lymphoma 2018.
    Br J Dermatol. 2019;180:443-444.
    PubMed     Text format    


    February 2019
  4. DANGIEN A, Beylot-Barry M, Battistella M, Ram-Wolff C, et al
    Clinical presentation, therapeutic approach and outcome of primary cutaneous marginal zone B-cell lymphoma presenting as AL amyloidoma of the skin.
    Br J Dermatol. 2019 Feb 22. doi: 10.1111/bjd.17821.
    PubMed     Text format     Abstract available


    January 2019
  5. ENZAN N, Kitadate A, Tanaka A, Matsue K, et al
    Incisional random skin biopsy, not punch biopsy, is an appropriate method for diagnosis of intravascular large B-cell lymphoma: A clinicopathological study of 25 patients.
    Br J Dermatol. 2019 Jan 4. doi: 10.1111/bjd.17603.
    PubMed     Text format     Abstract available


    December 2018
  6. GILSON D, Whittaker SJ, Child FJ, Scarisbrick JJ, et al
    British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous lymphomas 2018.
    Br J Dermatol. 2018 Dec 17. doi: 10.1111/bjd.17240.
    PubMed     Text format    


    October 2018
  7. BONNET P, Battistella M, Bouaziz JD, Ram-Wolff C, et al
    Thymic localization of erythrodermic cutaneous T-cell lymphoma.
    Br J Dermatol. 2018 Oct 19. doi: 10.1111/bjd.17340.
    PubMed     Text format     Abstract available


  8. DESCHAMPS O, Ram-Wolff C, Beylot-Barry M, Grange F, et al
    Treatment of mycosis fungoides and Sezary syndrome with romidepsin: a series of 32 cases of the French Study Group for Cutaneous Lymphoma.
    Br J Dermatol. 2018 Oct 9. doi: 10.1111/bjd.17269.
    PubMed     Text format     Abstract available


  9. MIURA H
    Image Gallery: 308-nm ultraviolet B excimer laser treatment for cutaneous B-cell lymphoma nodular lesions on the face.
    Br J Dermatol. 2018;179:e166.
    PubMed     Text format    


    September 2018
  10. DEENEN NJ, Koens L, Jaspars EH, Vermeer MH, et al
    Pitfalls in diagnosing primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma.
    Br J Dermatol. 2018 Sep 27. doi: 10.1111/bjd.17252.
    PubMed     Text format     Abstract available


  11. KEMPF W
    Multifocal anaplastic large cell lymphoma - insight into its biology and treatment.
    Br J Dermatol. 2018;179:565-566.
    PubMed     Text format    


    July 2018
  12. CONNOLLY A, Grandi V, Stefanato CM, Palmer R, et al
    Primary cutaneous CD30(+) anaplastic large cell lymphoma associated with fingolimod.
    Br J Dermatol. 2018 Jul 14. doi: 10.1111/bjd.17003.
    PubMed     Text format     Abstract available


    May 2018
  13. CHRISTENSEN L, Cooper K, Honda K, Mansur D, et al
    Relapse rates in patients with unilesional primary cutaneous B cell lymphoma treated with radiation therapy: a single-institution experience.
    Br J Dermatol. 2018 May 15. doi: 10.1111/bjd.16783.
    PubMed     Text format     Abstract available


    March 2018
  14. MELCHERS RC, Willemze R, Bekkenk MW, de Haas ERM, et al
    Evaluation of treatment results in multifocal primary cutaneous anaplastic large cell lymphoma: Report of the Dutch Cutaneous Lymphoma Group.
    Br J Dermatol. 2018 Mar 1. doi: 10.1111/bjd.16501.
    PubMed     Text format     Abstract available


    February 2018
  15. ORLOWSKA D, Selman LE, Beynon T, Radcliffe E, et al
    "It's a traumatic illness, traumatic to witness." A qualitative study of the experiences of bereaved family caregivers of patients with cutaneous T-cell lymphoma.
    Br J Dermatol. 2018 Feb 16. doi: 10.1111/bjd.16447.
    PubMed     Text format     Abstract available


    January 2018
  16. KWATRA SG, Boozalis E, Kwatra MM
    Effects of neuroimmune axis modulation by aprepitant on anti-pruritic and global disease severity in patients with cutaneous T-cell lymphoma.
    Br J Dermatol. 2018 Jan 20. doi: 10.1111/bjd.16363.
    PubMed     Text format     Abstract available


  17. HURABIELLE C, Leboeuf C, Ram-Wolff C, Meignin V, et al
    KIR3DL2 expression in patients with adult T-cell lymphoma/leukemia.
    Br J Dermatol. 2018 Jan 8. doi: 10.1111/bjd.16322.
    PubMed     Text format     Abstract available


    December 2017
  18. KAMSTRUP MR, Skov L, Zachariae C, Thyssen JP, et al
    Psoriasis and risk of malignant lymphoma: A population-based cohort study.
    Br J Dermatol. 2017 Dec 16. doi: 10.1111/bjd.16245.
    PubMed     Text format     Abstract available


  19. GONZALEZ-QUESADA A, Bastida J, Rivero-Vera JC, Piris-Pinilla MA, et al
    Image Gallery: Metachronic occurrence of primary cutaneous marginal zone B-cell lymphoma and primary cutaneous Rosai-Dorfman disease in the same patient.
    Br J Dermatol. 2017;177:e355.
    PubMed     Text format    


  20. SCARISBRICK JJ
    Brentuximab vedotin is an effective therapy for CD30(+) mycosis fungoides and cutaneous anaplastic large-cell lymphoma: what is the cost?
    Br J Dermatol. 2017;177:1474-1475.
    PubMed     Text format    


  21. LUO Y, Liu J
    Image Gallery: Primary cutaneous precursor B-lymphoblastic lymphoma in an infant.
    Br J Dermatol. 2017;177:e353.
    PubMed     Text format    


    November 2017
  22. CHEN L, Zhao X, Shi R, Zheng J, et al
    Image Gallery: Intravascular large B-cell lymphoma presenting with generalized telangiectasia.
    Br J Dermatol. 2017;177:e223.
    PubMed     Text format    


    October 2017
  23. GELLER S, Myskowski PL, Kim YH, Moskowitz A, et al
    The optimal regimen of brentuximab vedotin for CD30+ cutaneous lymphoma: Are we there yet?
    Br J Dermatol. 2017 Oct 10. doi: 10.1111/bjd.16052.
    PubMed     Text format     Abstract available


    September 2017
  24. STRANZENBACH R, Dippel E, Schlaak M, Stadler R, et al
    Alternate dosing regimens of brentuximab vedotin for CD30+ cutaneous T-cell lymphoma: reply from authors.
    Br J Dermatol. 2017 Sep 10. doi: 10.1111/bjd.15972.
    PubMed     Text format     Abstract available


  25. LEWIS DJ, Kim YH, Duvic M
    Alternate dosing regimens of brentuximab vedotin for CD30+ cutaneous T-cell lymphoma.
    Br J Dermatol. 2017 Sep 10. doi: 10.1111/bjd.15970.
    PubMed     Text format     Abstract available


  26. LIAW TY, Liang CW
    Image Gallery: Generalized annular figurate erythema as an unusual presentation of angioimmunoblastic T-cell lymphoma.
    Br J Dermatol. 2017;177:e75.
    PubMed     Text format    


  27. TENSEN CP, Vermeer MH
    MicroRNA-155 potentiates tumour development in mycosis fungoides.
    Br J Dermatol. 2017;177:618-620.
    PubMed     Text format    


    August 2017
  28. DE BRITO M, Gazzani P, Amel-Kashipaz R, Vydianath B, et al
    Image Gallery: Secondary cutaneous involvement of the ear with systemic small lymphocytic lymphoma: a rare manifestation.
    Br J Dermatol. 2017;177:e26.
    PubMed     Text format    


  29. DAWE RS
    Maintenance therapy with psoralen-ultraviolet A for mycosis fungoides: in the absence of evidence sitting on the fence is appropriate.
    Br J Dermatol. 2017;177:337-338.
    PubMed     Text format    


  30. VIEYRA-GARCIA P, Wolf P
    Psoralen-ultraviolet A maintenance in mycosis fungoides: the underlying question.
    Br J Dermatol. 2017;177:336-337.
    PubMed     Text format    


    July 2017
  31. BAUER WM, Aichelburg MC, Griss J, Skrabs C, et al
    Molecular Classification of Tumor Cells in a Patient with Intravascular Large B-Cell Lymphoma.
    Br J Dermatol. 2017 Jul 22. doi: 10.1111/bjd.15841.
    PubMed     Text format     Abstract available


  32. STRANZENBACH R, Dippel E, Schlaak M, Stadler R, et al
    Brentuximab vedotin in CD30+ cutaneous lymphoma: How do we treat - How shall we treat? A review of the literature.
    Br J Dermatol. 2017 Jul 13. doi: 10.1111/bjd.15801.
    PubMed     Text format     Abstract available


  33. BAGOT M
    Folliculotropic mycosis fungoides is a heterogenous group.
    Br J Dermatol. 2017;177:17-18.
    PubMed     Text format    


    June 2017
  34. LEE WJ, Kim YJ, Lee YJ, Won CH, et al
    VEGF protein expression is associated with a poor prognosis in cutaneous extranodal NK/T-cell lymphoma patients.
    Br J Dermatol. 2017 Jun 9. doi: 10.1111/bjd.15720.
    PubMed     Text format     Abstract available


  35. ADAMSKI H, Ingen-Housz-Oro S, Machet L, Carriou AC, et al
    Lymphomatoid papulosis associated with chronic lymphocytic leukemia/small lymphocytic lymphoma: 3 cases.
    Br J Dermatol. 2017 Jun 1. doi: 10.1111/bjd.15698.
    PubMed     Text format     Abstract available


    May 2017
  36. SCARISBRICK JJ
    Prognostic factors in mycosis fungoides: international advances in the validation of prognostic indices.
    Br J Dermatol. 2017;176:1129-1130.
    PubMed     Text format    


    April 2017
  37. KEMPF W
    Cutaneous lymphomas in childhood and adolescence: much needed new data.
    Br J Dermatol. 2017;176:857-858.
    PubMed     Text format    


    August 2016
  38. GRIJSEN ML, Mtayangulwa RG, Naafs B, Jansen P, et al
    The clinical spectrum of mycosis fungoides in Tanzania, East-Africa.
    Br J Dermatol. 2016 Aug 16. doi: 10.1111/bjd.14963.
    PubMed     Text format     Abstract available


  39. KEMPF W
    TOX - what role does it play in cutaneous lymphomas?
    Br J Dermatol. 2016;175:248-9.
    PubMed     Text format    


  40. ORTIZ-ROMERO PL
    Targeting KIR3DL2 in primary cutaneous anaplastic large cell lymphomas.
    Br J Dermatol. 2016;175:246-7.
    PubMed     Text format    


    July 2016
  41. SCARISBRICK JJ
    Cutaneous T-cell lymphomas: an urgent need for more improved therapies.
    Br J Dermatol. 2016;175:14-5.
    PubMed     Text format    


    May 2016
  42. LECAMWASAM K, Mathew B, Gilson D, Burton C, et al
    Correspondence article regarding CD68 as a marker of CD8+ lymphoid proliferation suggested by Wobser et al.
    Br J Dermatol. 2016;174:1158-9.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: